Other studies reveal another mechanism using murine brain cancer models: activated mammalian target of rapamycin (mTOR) signaling pathway followed by PGRN binding to TNFR2 was identified in malignant cervical cancer cells, whereas the inhibition of mTOR suppressed malignant transformation and tumor growth [38]. Here, MTOR is linked to brain cancer.